Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

UNH vs MCK

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
UNH
UnitedHealth Group Incorporated

Medical - Healthcare Plans

HealthcareNYSE • US
Market Cap$330.28B
5Y Perf.+19.4%
MCK
McKesson Corporation

Medical - Distribution

HealthcareNYSE • US
Market Cap$98.11B
5Y Perf.+404.8%

UNH vs MCK — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
UNH logoUNH
MCK logoMCK
IndustryMedical - Healthcare PlansMedical - Distribution
Market Cap$330.28B$98.11B
Revenue (TTM)$449.71B$397.96B
Net Income (TTM)$12.04B$4.34B
Gross Margin18.8%3.4%
Operating Margin4.2%1.3%
Forward P/E19.9x20.5x
Total Debt$78.39B$7.39B
Cash & Equiv.$24.36B$5.69B

UNH vs MCKLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

UNH
MCK
StockMay 20May 26Return
UnitedHealth Group … (UNH)100119.4+19.4%
McKesson Corporation (MCK)100504.8+404.8%

Price return only. Dividends and distributions are not included.

Quick Verdict: UNH vs MCK

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: MCK leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and capital preservation and lower volatility. UnitedHealth Group Incorporated is the stronger pick specifically for valuation and capital efficiency and profitability and margin quality. As sector peers, any of these can serve as alternatives in the same allocation.
UNH
UnitedHealth Group Incorporated
The Insurance Pick

UNH is the clearest fit if your priority is income & stability.

  • Dividend streak 25 yrs, beta 0.59, yield 2.4%
  • Lower P/E (19.9x vs 20.5x)
  • 2.7% margin vs MCK's 1.1%
Best for: income & stability
MCK
McKesson Corporation
The Growth Play

MCK carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 16.2%, EPS growth 14.9%, 3Y rev CAGR 10.8%
  • 375.1% 10Y total return vs UNH's 217.0%
  • Lower volatility, beta 0.04, current ratio 0.90x
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthMCK logoMCK16.2% revenue growth vs UNH's 11.8%
ValueUNH logoUNHLower P/E (19.9x vs 20.5x)
Quality / MarginsUNH logoUNH2.7% margin vs MCK's 1.1%
Stability / SafetyMCK logoMCKBeta 0.04 vs UNH's 0.59
DividendsUNH logoUNH2.4% yield, 25-year raise streak, vs MCK's 0.3%
Momentum (1Y)MCK logoMCK+13.7% vs UNH's -7.9%
Efficiency (ROA)MCK logoMCK5.3% ROA vs UNH's 3.9%, ROIC 5.4% vs 9.2%

UNH vs MCK — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

UNHUnitedHealth Group Incorporated
FY 2025
Unitedhealthcare
94.4%$332.4B
Optumhealth
5.6%$19.8B
MCKMcKesson Corporation
FY 2025
U.S. Pharmaceutical Segment
91.3%$327.7B
International Segment
4.1%$14.7B
Medical-Surgical Solutions Segment
3.2%$11.4B
Prescription Technology Solutions
1.5%$5.2B

UNH vs MCK — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLUNHLAGGINGMCK

Income & Cash Flow (Last 12 Months)

UNH leads this category, winning 4 of 6 comparable metrics.

UNH and MCK operate at a comparable scale, with $449.7B and $398.0B in trailing revenue. Profitability is closely matched — net margins range from 2.7% (UNH) to 1.1% (MCK). On growth, MCK holds the edge at +11.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricUNH logoUNHUnitedHealth Grou…MCK logoMCKMcKesson Corporat…
RevenueTrailing 12 months$449.7B$398.0B
EBITDAEarnings before interest/tax$23.2B$5.8B
Net IncomeAfter-tax profit$12.0B$4.3B
Free Cash FlowCash after capex$19.7B$10.1B
Gross MarginGross profit ÷ Revenue+18.8%+3.4%
Operating MarginEBIT ÷ Revenue+4.2%+1.3%
Net MarginNet income ÷ Revenue+2.7%+1.1%
FCF MarginFCF ÷ Revenue+4.4%+2.5%
Rev. Growth (YoY)Latest quarter vs prior year+2.0%+11.4%
EPS Growth (YoY)Latest quarter vs prior year+0.7%+38.2%
UNH leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

UNH leads this category, winning 3 of 5 comparable metrics.

At 27.5x trailing earnings, UNH trades at a 12% valuation discount to MCK's 31.1x P/E. On an enterprise value basis, UNH's 16.5x EV/EBITDA is more attractive than MCK's 19.9x.

MetricUNH logoUNHUnitedHealth Grou…MCK logoMCKMcKesson Corporat…
Market CapShares × price$330.3B$98.1B
Enterprise ValueMkt cap + debt − cash$384.3B$99.8B
Trailing P/EPrice ÷ TTM EPS27.50x31.14x
Forward P/EPrice ÷ next-FY EPS est.19.87x20.53x
PEG RatioP/E ÷ EPS growth rate0.80x
EV / EBITDAEnterprise value multiple16.48x19.93x
Price / SalesMarket cap ÷ Revenue0.74x0.27x
Price / BookPrice ÷ Book value/share3.26x
Price / FCFMarket cap ÷ FCF20.55x18.77x
UNH leads this category, winning 3 of 5 comparable metrics.

Profitability & Efficiency

MCK leads this category, winning 6 of 6 comparable metrics.
MetricUNH logoUNHUnitedHealth Grou…MCK logoMCKMcKesson Corporat…
ROE (TTM)Return on equity+11.5%
ROA (TTM)Return on assets+3.9%+5.3%
ROICReturn on invested capital+9.2%+5.4%
ROCEReturn on capital employed+9.7%+30.5%
Piotroski ScoreFundamental quality 0–966
Debt / EquityFinancial leverage0.77x
Net DebtTotal debt minus cash$54.0B$1.7B
Cash & Equiv.Liquid assets$24.4B$5.7B
Total DebtShort + long-term debt$78.4B$7.4B
Interest CoverageEBIT ÷ Interest expense4.71x25.04x
MCK leads this category, winning 6 of 6 comparable metrics.

Total Returns (Dividends Reinvested)

MCK leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in MCK five years ago would be worth $43,011 today (with dividends reinvested), compared to $9,722 for UNH. Over the past 12 months, MCK leads with a +13.7% total return vs UNH's -7.9%. The 3-year compound annual growth rate (CAGR) favors MCK at 30.3% vs UNH's -7.7% — a key indicator of consistent wealth creation.

MetricUNH logoUNHUnitedHealth Grou…MCK logoMCKMcKesson Corporat…
YTD ReturnYear-to-date+8.8%-2.6%
1-Year ReturnPast 12 months-7.9%+13.7%
3-Year ReturnCumulative with dividends-21.4%+121.2%
5-Year ReturnCumulative with dividends-2.8%+330.1%
10-Year ReturnCumulative with dividends+217.0%+375.1%
CAGR (3Y)Annualised 3-year return-7.7%+30.3%
MCK leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — UNH and MCK each lead in 1 of 2 comparable metrics.

MCK is the less volatile stock with a 0.04 beta — it tends to amplify market swings less than UNH's 0.59 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. UNH currently trades 88.8% from its 52-week high vs MCK's 80.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricUNH logoUNHUnitedHealth Grou…MCK logoMCKMcKesson Corporat…
Beta (5Y)Sensitivity to S&P 5000.59x0.04x
52-Week HighHighest price in past year$409.70$999.00
52-Week LowLowest price in past year$234.60$637.00
% of 52W HighCurrent price vs 52-week peak+88.8%+80.2%
RSI (14)Momentum oscillator 0–10083.327.7
Avg Volume (50D)Average daily shares traded8.1M690K
Evenly matched — UNH and MCK each lead in 1 of 2 comparable metrics.

Analyst Outlook

UNH leads this category, winning 2 of 2 comparable metrics.

Wall Street rates UNH as "Buy" and MCK as "Buy". Consensus price targets imply 25.7% upside for MCK (target: $1007) vs 5.9% for UNH (target: $385). For income investors, UNH offers the higher dividend yield at 2.39% vs MCK's 0.34%.

MetricUNH logoUNHUnitedHealth Grou…MCK logoMCKMcKesson Corporat…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$385.43$1006.50
# AnalystsCovering analysts5231
Dividend YieldAnnual dividend ÷ price+2.4%+0.3%
Dividend StreakConsecutive years of raises2517
Dividend / ShareAnnual DPS$8.70$2.69
Buyback YieldShare repurchases ÷ mkt cap+1.7%+3.2%
UNH leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

UNH leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). MCK leads in 2 (Profitability & Efficiency, Total Returns). 1 tied.

Best OverallUnitedHealth Group Incorpor… (UNH)Leads 3 of 6 categories
Loading custom metrics...

UNH vs MCK: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is UNH or MCK a better buy right now?

For growth investors, McKesson Corporation (MCK) is the stronger pick with 16.

2% revenue growth year-over-year, versus 11. 8% for UnitedHealth Group Incorporated (UNH). UnitedHealth Group Incorporated (UNH) offers the better valuation at 27. 5x trailing P/E (19. 9x forward), making it the more compelling value choice. Analysts rate UnitedHealth Group Incorporated (UNH) a "Buy" — based on 52 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — UNH or MCK?

On trailing P/E, UnitedHealth Group Incorporated (UNH) is the cheapest at 27.

5x versus McKesson Corporation at 31. 1x. On forward P/E, UnitedHealth Group Incorporated is actually cheaper at 19. 9x.

03

Which is the better long-term investment — UNH or MCK?

Over the past 5 years, McKesson Corporation (MCK) delivered a total return of +330.

1%, compared to -2. 8% for UnitedHealth Group Incorporated (UNH). Over 10 years, the gap is even starker: MCK returned +375. 1% versus UNH's +217. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — UNH or MCK?

By beta (market sensitivity over 5 years), McKesson Corporation (MCK) is the lower-risk stock at 0.

04β versus UnitedHealth Group Incorporated's 0. 59β — meaning UNH is approximately 1261% more volatile than MCK relative to the S&P 500.

05

Which is growing faster — UNH or MCK?

By revenue growth (latest reported year), McKesson Corporation (MCK) is pulling ahead at 16.

2% versus 11. 8% for UnitedHealth Group Incorporated (UNH). On earnings-per-share growth, the picture is similar: McKesson Corporation grew EPS 14. 9% year-over-year, compared to -14. 7% for UnitedHealth Group Incorporated. Over a 3-year CAGR, UNH leads at 11. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — UNH or MCK?

UnitedHealth Group Incorporated (UNH) is the more profitable company, earning 2.

7% net margin versus 0. 9% for McKesson Corporation — meaning it keeps 2. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UNH leads at 4. 2% versus 1. 2% for MCK. At the gross margin level — before operating expenses — UNH leads at 18. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is UNH or MCK more undervalued right now?

On forward earnings alone, UnitedHealth Group Incorporated (UNH) trades at 19.

9x forward P/E versus 20. 5x for McKesson Corporation — 0. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MCK: 25. 7% to $1006. 50.

08

Which pays a better dividend — UNH or MCK?

All stocks in this comparison pay dividends.

UnitedHealth Group Incorporated (UNH) offers the highest yield at 2. 4%, versus 0. 3% for McKesson Corporation (MCK).

09

Is UNH or MCK better for a retirement portfolio?

For long-horizon retirement investors, McKesson Corporation (MCK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

04), +375. 1% 10Y return). Both have compounded well over 10 years (MCK: +375. 1%, UNH: +217. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between UNH and MCK?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: UNH is a large-cap quality compounder stock; MCK is a mid-cap high-growth stock. UNH pays a dividend while MCK does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

UNH

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Dividend Yield > 0.9%
Run This Screen
Stocks Like

MCK

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Dividend Yield > 0.5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform UNH and MCK on the metrics below

Revenue Growth>
%
(UNH: 2.0% · MCK: 11.4%)
P/E Ratio<
x
(UNH: 27.5x · MCK: 31.1x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.